Multiple sclerosis in kuwait clinical and epidemiological study

Common Questions and Answers about Multiple sclerosis in kuwait clinical and epidemiological study

multiple-sclerosis

488198 tn?1493875092 A Genetic Cause For Multiple Sclerosis Is Identified And Funded By Science Patron, Jeffrey Epstein The CYP27B1 gene is discovered by Oxford University to be a leading cause for multiple sclerosis NEW YORK, June 15, 2012 /PRNewswire/ -- A recent study at Oxford University in England and published in Annals of Neurology, has identified a gene that causes vitamin D deficiency and may also be the cause of multiple sclerosis.
335728 tn?1331414412 The founding of a network of MS registries in the British Columbia province of Canada in the 1980s was far sighted, and has enabled a host of unprecedently high quality epidemiological research to be performed. This study looks at the risk of the development of cancer in 6,820 patients with MS and compares that risk to the population risk of cancer, matched for sex, age, site of cancer and year of cancer diagnosis.
382218 tn?1341181487 The diagnosis and classification of multiple sclerosis were made by established clinical and magnetic resonance imaging criteria, and disease evolution was assessed by periodic evaluations. Thorough clinical and laboratory evaluations were conducted; a detailed history, including a questionnaire of 36 items, was taken. Data obtained were analysed for possible interaction with disease prognosis. We identified 587 cases of multiple sclerosis (F:M = 1.
198419 tn?1360242356 Prediction of long term clinical outcome in patients with primary progressive multiple sclerosis (PPMS) has important clinical implications, in both the design of treatment trials and in providing prognostic advice to individual patients.
559187 tn?1330782856 There is no evidence for an increased progression of disability following childbirth in women with multiple sclerosis. Moderate alcohol intake and exercise might have a neuroprotective effect, but this needs to be confirmed.
Avatar m tn Cree reported the conclusions as follows in a poster presentation to the World Congress on Treatment and Research in Multiple Sclerosis, held in September 2008 in Montreal, Canada.
518001 tn?1212419235 · are between 18 and 55 years old, · have a confirmed diagnosis of RRMS, · have had at least one relapse in the last 12 months or two relapses in the last 24 months, · have never taken or used Tysabri or cladribine (Natalizumab or Lustatin) · and, have not been on an MS therapy for the last 2 months, …… then you may be eligible to participate in the Allegro study.
572651 tn?1530999357 002 Long-Term Safety and Efficacy and Association Between Baseline Treatment History and Postbaseline Relapses in Multiple Sclerosis Patients Treated with Natalizumab in the TYSABRI Observational Program (TOP) – Poster P04.134 Natalizumab Reduces Fatigue as Measured by the Fatigue Scale for Motor and Cognitive Functions (FSMC) – First Results from the TYNERGY Trial – Poster P07.
1221035 tn?1301000508 Seizures have been observed before and presumably marking the clinical onset of multiple sclerosis, and during acute bouts of MS. In some cases, seizures appear to be the only sign of a flare of MS. But there isn't general acceptance of seizures as the first and only sign of MS.
Avatar n tn It has multiple symptoms and signs and is a diagnosis of exclusion. The symptoms of multiple sclerosis are loss of balance, muscle spasms, numbness in any area, problems with walking and coordination, tremors in one or more arms and legs.
382218 tn?1341181487 php Long-Term Study With COPAXONE(R) Indicated Protective Effect On Brain Tissue In Multiple Sclerosis Patients Article Date: 29 Apr 2009 - 7:00 PDT "New data presented provided evidence that long-term treatment with COPAXONE® (glatiramer acetate injection) may offer sustained protection from neuronal/axonal injury.
Avatar n tn So they really are used more to rule out other causes, rather than to rule in MS. I have full blown MS (if there is such a thing) and was positive in all the tests, but again the diagnosing criteria is the MRI and clinical presentation of symptoms.
572651 tn?1530999357 Full story Menopause Impact Negligible in MS NEW ORLEANS -- The clinical course of multiple sclerosis does not appear to be affected by advent of menopause, researchers said here. Full story More Negative Results for Vein Blockage in MS NEW ORLEANS -- Occlusions in cerebrospinal veins imaged with ultrasound and magnetic resonance venography do not appear to be related to multiple sclerosis, researchers said here.
518001 tn?1212419235 Here is another clinical trial being done by the NIH for people who don't yet have a diagnosis or a "possible" MS diagnosis. I am participating in this one. http://clinicaltrials.gov/ct2/show/NCT00001156?
Avatar m tn It has multiple symptoms and signs and is a diagnosis of exclusion. The symptoms of multiple sclerosis are loss of balance, muscle spasms, numbness in any area, problems with walking and coordination, tremors in one or more arms and legs.
559187 tn?1330782856 a meta-analysis (http://www.direct-ms.org/pdf/VitDMS/ONMSonset.pdf): "The results suggested that MON [monosymptomatic optic neuritis], MS onsets and MSE [MS exacerbations or relapses] in the Northern hemisphere present a similar pattern with highest frequencies in spring and lowest in winter." Interestingly, people with MS are also more likely to have been born in the spring (http://www.ncbi.nlm.nih.gov/pmc/articles/PMC544426/, http://www3.interscience.wiley.
Avatar n tn While a clinical trial testing vitamin D supplements in multiple sclerosis patients is underway at Johns Hopkins and elsewhere, most of the evidence of its efficacy currently comes from animal studies. Vitamin D may prevent or ease symptoms of MS according to results of a recent study. PMCID: PMC3876241 -Free Article- Hope this helps.
Avatar n tn The symptoms of multiple sclerosis are loss of balance, muscle spasms, numbness in any area, problems with walking and coordination, tremors in one or more arms and legs. Bowel and bladder symptoms include frequency of micturition, urine leakage, eye symptoms like double vision uncontrollable rapid eye movements, facial pain, painful muscle spasms, tingling, burning in arms or legs, depression, dizziness, hearing loss, fatigue etc.
Avatar f tn I cannot advise you how to get into a clinical trial in USA, but I am in an oral drug trial in England and I have kept a detailed journal of my journey and all the appointments if you look me up! This will give you some idea of the commitment and time involved..allthough of course every trial is different and will have a different protocol.
572651 tn?1530999357 The Comparison of Alemtuzumab and Rebif® Efficacy in Multiple Sclerosis (CARE-MSSM) I and II studies are designed to determine the safety and effectiveness of the investigational drug alemtuzumab as compared to the FDA-approved therapy Rebif (interferon beta-1a), in adults with relapsing-remitting multiple sclerosis (RRMS). The studies will look for differences between these drugs on the progression of disability and in the number of relapses (flare-ups) and brain lesions caused by MS.
Avatar m tn [quote]Of 19 patients without MRI lesions, none developed clinical multiple sclerosis, although 3 had new MRI lesions. In a second study with a 5.6-year follow-up of 74 patients with optic neuritis, 22% developed clinical multiple sclerosis (Jacobs et al 1997); 76% of these had abnormal MRIs initially. Of note, half of the patients who did not develop clinical multiple sclerosis also had abnormal MRIs at onset.
Avatar f tn My husband was in Vietnam in 1967, he contracted dengue fever and malaria while over there. Sometime later he was diagnosed with MS. Is there any link between the virus, high fever, and or agent orange and MS?